ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 995,29
1,02%
Dow Jones
38 225,66
0,00%
DAX
18 075,45
0,95%
Brent Oil
83,77
0,17%
Bitcoin
60 428,43
2,20%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TELA Bio Inc (TELA)

  7. TELA Bio Inc (TELA) Actualités

TELA TELA Bio Inc

4,63
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:16:44
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
TELA Bio Inc TELA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 4,63 10:16:44
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,63
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/4/202413:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/4/202413:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21/3/202421:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21/3/202412:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20/3/202412:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
29/2/202413:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
27/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
14/2/202423:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202412:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/1/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
15/12/202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
07/12/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202313:00GLOBETELA Bio to Take Part in Connecting the Dots
16/11/202313:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
15/11/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:44EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202322:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/11/202322:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
26/10/202313:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
20/10/202322:06EDGAR2Form 8-K - Current report
06/10/202317:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/9/202322:05EDGAR2Form 8-K - Current report
18/9/202322:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
16/8/202313:15EDGAR2Form 8-K - Current report
16/8/202313:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
10/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
04/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202322:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202322:02GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
26/7/202313:00GLOBETELA Bio to Announce Second Quarter 2023 Financial Results..
15/6/202313:00GLOBENew Survey Finds Strong Consumer Preference for More Natural..
25/5/202313:00GLOBETELA Bio to Participate in the Jefferies Global Healthcare..
19/5/202313:00GLOBETELA Bio Invests in Surgeon Training and Education with..
11/5/202322:02GLOBETELA Bio Reports First Quarter 2023 Financial Results
09/5/202313:00GLOBETELA Bio Supports Diversity and Inclusion at International..
08/5/202322:30GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..

Dernières Valeurs Consultées

NASDAQ
TELA
TELA Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés